Target
Serine/threonine-protein kinase WNK1 [166-489]
Ligand
BDBM203827
Substrate
n/a
Meas. Tech.
In vitro MBP Phosphorylation Assay (MBP)
pH
7.3±n/a
Temperature
298.15±n/a K
IC50
1±0.0 nM
Comments
extracted
Citation
 Yamada, KPark, HMRigel, DFDiPetrillo, KWhalen, EJAnisowicz, ABeil, MBerstler, JBrocklehurst, CEBurdick, DACaplan, SLCapparelli, MPChen, GChen, WDale, BDeng, LFu, FHamamatsu, NHarasaki, KHerr, THoffmann, PHu, QYHuang, WJIdamakanti, NImase, HIwaki, YJain, MJeyaseelan, JKato, MKaushik, VKKohls, DKunjathoor, VLaSala, DLee, JLiu, JLuo, YMa, FMo, RMowbray, SMogi, MOssola, FPandey, PPatel, SJRaghavan, SSalem, BShanado, YHTrakshel, GMTurner, GWakai, HWang, CWeldon, SWielicki, JBXie, XXu, LYagi, YIYasoshima, KYin, JYowe, DZhang, JHZheng, GMonovich, L Small-molecule WNK inhibition regulates cardiovascular and renal function. Nat Chem Biol 12:896-898 (2016) [PubMed]  Article 
Target
Name:
Serine/threonine-protein kinase WNK1 [166-489]
Synonyms:
HSN2 | KDP | KIAA0344 | PRKWNK1 | WNK1 | WNK1_HUMAN | With-No-Lysine (K) Kinase 2 (WNK2)
Type:
n/a
Mol. Mass.:
36752.73
Organism:
Homo sapiens (Human)
Description:
Q9H4A3 166-489 aa Carna Biosciences, cat no. 05-180
Residue:
324
Sequence:
VSQPSLVGSKEEPPPARSGSGGGSAKEPQEERSQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKSVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEETGVRVEL
  
Inhibitor
Name:
BDBM203827
Synonyms:
N-(tert-butyl)-1-(1-(5-(5-(trifluoromethyl)-1,3,4-oxadiazol- 2-yl)pyridin-2-yl)piperidin-4-yl)-1H-imidazole-5-carboxamide | WNK463 | WNK463 (2)
Type:
Small organic molecule
Emp. Form.:
C22H25F3N6O2
Mol. Mass.:
462.4681
SMILES:
CC(C)(C)NC(=O)c1cncn1C1CCN(CC1)c1ccc(cc1)-c1nnc(o1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: